Medical research

Inhalable COVID vaccine shows promise in rodent model

Researchers have created an inhalable COVID-19 vaccine that is shelf stable at room temperature for up to three months, targets the lungs specifically and effectively, and allows for self-administration via an inhaler. The ...

Oncology & Cancer

Developing a new treatment for lung cancer

In Norway, more than 3,300 people contract lung cancer every year. It is the second most common form of cancer among both women and men, after breast and prostate cancer, respectively. It also exhibits the highest cancer ...

Immunology

A third vaccine dose may increase protection from omicron

The mRNA vaccines used against COVID were never designed to battle the omicron variant, a now dominant strain of the coronavirus that recently claimed 18,000 lives in a single week. Yet individuals who receive their third ...

Vaccination

Rwanda breaks ground on first mRNA vaccine plant

Rwanda and German pharma company BioNTech broke ground Thursday on Africa's first mRNA vaccine factory where cutting-edge treatments for diseases like COVID-19 will be made for millions across the continent.

Vaccination

Long wait over as US vaccinates youngest against COVID

US hospitals, clinics and pharmacies began vaccinating the nation's youngest children against COVID-19 on Tuesday, a milestone that was welcomed by parents eager to protect kids from the worst impacts of the virus.

Vaccination

Moderna to build UK centre for mRNA vaccines

Moderna and the UK government on Wednesday announced a deal for the US biotech firm to build a cutting-edge centre to develop and produce mRNA vaccines for respiratory diseases, including COVID.

page 13 from 33